Skip to main content
PLOS One logoLink to PLOS One
. 2025 Nov 25;20(11):e0336922. doi: 10.1371/journal.pone.0336922

Interventions to improve racial and ethnic equity in critical care: A scoping review

Shirley Ge 1,2,¤, Hope Lappen 3, Luz Mercado 2, Kaylee Lamarche 2, Theodore J Iwashyna 4, Catherine L Hough 5, Virginia W Chang 2,6, Adolfo Cuevas 2, Thomas S Valley 7,8,9,10, Mari Armstrong-Hough 2,11,*
Editor: De-Chih Lee12
PMCID: PMC12646404  PMID: 41289298

Abstract

Background

Racial and ethnic disparities in the delivery and outcomes of critical care are well documented. However, interventions to mitigate these disparities are less well understood. We sought to review the current state of evidence for interventions to promote equity in critical care processes and patient outcomes.

Methods

Four bibliographic databases (MEDLINE/PubMed, Web of Science Core Collection, CINAHL, and Embase) and a list of core journals, conference abstracts, and clinical trial registries were queried with a pre-specified search strategy. We analyzed the content of interventions by categorizing each as single- or multi-component, extracting each intervention component during review, and grouping intervention components according to strategy to identify common approaches.

Results

The search strategy yielded 11,509 studies. Seven-thousand seventeen duplicate studies were removed, leaving 4,491 studies for title and abstract screening. After screening, 93 studies were included for full-text review. After full-text review by two independent reviewers, eleven studies met eligibility criteria. We identified ten distinct intervention components under five broad categories: education, communication, standardization, restructuring, and outreach. Most examined effectiveness using pre-post or other non-randomized designs.

Conclusions

Despite widespread recognition of disparities in critical care outcomes, few interventions have been evaluated to address disparities in the ICU. Many studies did not describe the rationale or targeted disparity mechanism for their intervention design. There is a need for randomized, controlled evaluations of interventions that target demonstrated mechanisms for disparities to promote equity in critical care.

Introduction

Disparities in the delivery and outcomes of critical care are well documented [15]. Black patients are less likely to receive timely or guideline-concordant antibiotics [6], Hispanic patients are more likely to receive deep sedation, and both Black and Hispanic patients are less likely to receive timely tracheostomy [79]. Black and Hispanic patients also have higher rates of sepsis and mortality from acute respiratory distress syndrome compared to White patients [10,11]. Furthermore, Black patients have higher incidence of venous thromboembolism and noncardiogenic respiratory failure [1215].

Racial and ethnic disparities in outcomes of pediatric critical care are also well recognized. In the neonatal intensive care unit (NICU) setting, non-White infants have a two-fold greater risk of mortality related to intraventricular hemorrhage (IVH) and are less likely to survive necrotizing enterocolitis (NEC) [16,17]. Non-White infants are also less likely to be discharged on breastmilk feeding, which is associated with lower incidence of IVH, NEC, neurodevelopmental delays, late-onset sepsis, and chronic lung disease [1823].

As the coronavirus disease 2019 pandemic disproportionately sickened Black, Hispanic, and Native American populations, awareness of inequities in critical care and interest in interventions to combat disparities increased [24,25]. However, despite longstanding recognition of disparities in outcomes of critical care and increasing urgency to address them, few interventions to reduce disparities have been routinely deployed in the critical care setting [2,3]. We therefore aimed to review existing and ongoing studies of interventions that target racial or ethnic disparities in the delivery or outcomes of ICU care. The objective of this scoping review is to consolidate the available knowledge regarding interventions and quality improvement initiatives to reduce racial and ethnic disparities in critical care.

Methods

Literature search

This scoping review addressed the question, “What is the current state of evidence for interventions to reduce racial and ethnic disparities in critical care processes and patient outcomes?” To answer this question, we developed a review protocol based on a framework by Visintini, Evidence Synthesis Coordinator at the Maritime SPOR SUPPORT Unit [26]. A research librarian (HL) was consulted in study design and results analysis. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) standard was followed in reporting procedures and results [27,28] (S1 Checklist).

We included past and ongoing studies, trials, and initiatives with an interventional component that aimed to address racial/ethnic disparities in medical, surgical, and pediatric intensive care settings in the United States. We limited the scope of our review to the United States to enhance comparability of studies. Studies were excluded if they aimed only to detect the presence of a racial or ethnic disparity, lacked an intervention, were conducted outside the U.S., were not published in English, or did not take place in an intensive care setting or examine critical illnesses.

An iterative search methodology was employed to optimize the comprehensiveness of our literature search. First, four bibliographic databases (MEDLINE/PubMed, Web of Science Core Collection, CINAHL, and Embase) were queried with pre-specified search strategies. Journals, conference abstracts, and clinical trial registries were hand-searched using the same criteria. All sources were searched from inception until December 31, 2023 (S1 Database).

Databases were searched using an iterative approach that began with a focused search strategy which included terms on improvement, reduction, and intervention to quickly identify relevant articles (S1 Database). Diseases and devices common to the ICU setting (acute respiratory distress syndrome (ARDS), respiratory failure, extracorporeal membrane oxygenation (ECMO), and sepsis) were incorporated into search strategy to ensure any studies related to critical care medicine were captured. This initial, focused strategy is shown to demonstrate the overall structure of the search strategies. The search strategies for each database and iteration are reported in S1 Database:

(race OR racial OR ethnic*)

AND

(disparity OR disparities OR inequality OR inequalities OR inequity OR inequities)

AND

(icu OR critical care OR intensive care OR intensive care units OR critical illness OR ARDS OR respiratory failure OR ECMO OR sepsis)

AND

(quality improvement OR improvement OR improve OR reduction OR reduce OR intervention OR intervene).

Though “inequity” has a distinct meaning from “inequality” or “disparity”, health equity depends on addressing inequalities and disparities [29,30]; thus, the search terms “inequity” and “inequities” were used to capture all possible articles relevant disparity research. Following the first focused search, the databases were queried again using broader search strategies that removed terms specifying an interventional component and also integrated subject headings and additional ICU-related keywords to ensure the search was comprehensive.

After surveying the databases, sources that report ongoing studies were hand-searched. These included ClinicalTrials.gov, NIH RePORTER, MedRXiv, and the Veterans Affairs (VA) Health Services Research and Development citations database. The VA database reports both past and ongoing studies. Journals and conference abstracts from Society of Critical Care Medicine and the American Thoracic Society were also hand-searched for reports of past or ongoing studies. The resulting literature was imported into Covidence systematic review software for deduplication, screening, and extraction [31]. The studies were screened by title and abstract by one reviewer (SG). The remaining literature was full-text reviewed by two team members (SG, MAH) independently. Conflicts within the full-text screening regarding study exclusion or the specific reason for exclusion were discussed between the two reviewers and a third reviewer (HL) and resolved by consensus or a tie-breaking vote by the third reviewer. The reasons for exclusion were recorded per PRISMA-ScR guidelines. The two reviewers (SG, MAH) then each independently extracted the included studies and compared the extractions to reach a final consensus.

Analysis

Both reviewers extracted detailed characterizations of the interventions evaluated in the included studies. Because there is heterogeneity in how race and ethnicity were characterized and measured by investigators, reviewers also recorded how each study defined its target disparity and how demographic data were collected. Next, reviewers catalogued each intervention component and distinguished between complex interventions that bundled together multiple intervention components and simple interventions that consisted of a single intervention component [32]. Reviewers then discussed each intervention component and organized them into a taxonomy of intervention types and elements. The taxonomy was developed by grouping similar intervention components under a broad category and then further categorizing the components into more granular, specific classifications. By creating a taxonomy, we could compare the different interventional approaches among the included studies and identify patterns in current and previous interventions aimed at disparities.

Results

Literature search

For the first focused search, bibliographic database queries and hand-searches yielded 1,406 studies (Fig 1, S1 Database). The broad search of the databases resulted in 5,021 articles, and the second broad search with subject headings and additional terms resulted in 5,072 articles. Seven thousand seventeen duplicates were removed, leaving 4,491 studies for title and abstract screening of which 4,398 studies were deemed irrelevant. One report was merged because it was the study protocol for another study already added for screening [33,34]. After full-text review of the remaining 93 studies by two independent reviewers, 11 studies met eligibility criteria.

Fig 1. PRISMA-ScR Flowchart.

Fig 1

During full-text review, studies were excluded if they did not include a prospective assessment of an intervention (S1 Text). Eighty-two studies were excluded during full-text review, of which 34 studies (41%) were disqualified for ineligible study design. These studies lacked an intervention and either focused on investigating the mechanisms for disparities or discussed potential ways to address disparities without carrying out an evaluation. Twenty-one studies (26%) were excluded for “Formative research (no intervention)”, meaning they sought to detect or explore a racial/ethnic disparity but did not pilot an intervention to resolve the disparity. Two studies (2%) were omitted for “Wrong intervention” because the study intervention did not address a racial or ethnic disparity. In one study, investigators retrospectively assessed if a previously implemented protocol to reduce sepsis mortality had equitably benefited patients of racial or ethnic minority background, as opposed to designing and implementing an intervention to reduce a previously observed disparity [35]. The second excluded study examined how using a screening tool for social determinants of health in the NICU impacted patients and families, but did not directly address associated health disparities by race and ethnicity [36]. The 11 studies that remained after full-text review each had an interventional component to address a racial or ethnic disparity in care processes or outcomes in an intensive care setting in the United States.

Intervention targets and results

Table 1 summarizes the 11 included studies. Nine were single-center studies. Two were multicenter studies: the Massachusetts Human Milk QI Collaborative by Parker et al., a statewide QI initiative that involved all 10 level III NICUs in Massachusetts [37], and the Mayo Clinic Care Network (MCCN) Guiding Coalition by Linnander et al., a coalition-based leadership intervention across eight U.S. health systems and their surrounding communities [38]. Six studies (55%) were ongoing clinical trials [34,3842]. Two studies (18%) employed interventions that continued to be implemented past the study period [37,43].

Table 1. Population Summary.

Study Title & First Author Outcome Measure(s) Publication Type & Date Type of Study & Funding Sources Study Population Race Definition Pre-Intervention Period? Intervention(s) Tested & If There Was a Pre-Intervention Period
Impact of a Communication Intervention Around Goals of Care on Racial Disparities in End-of-Life Care in the Intensive Care Unit

Anne Mosenthal
Cardiopulmonary resuscitation, do-not-resuscitate, withdrawal of life support, and length of stay Conference abstract, 2010 Retrospective cohort study,

no funding sources
Black and non-Black MICU patients, presumably adults. No mention on how race data were obtained. No 1. Interdisciplinary rounds with prognosis evaluation

2. Facilitated family meetings around goals of care for those patients identified with poor prognosis.
Pediatric intensive care unit mortality among Latino children before and after a multilevel health care delivery intervention

Kanwaljeet J. S. Anand
Odds of mortality at PICU Discharge Peer-reviewed journal article, 2015 Observational study,

no funding sources
Pediatric patients (<= 18 yo) discharged from the PICU at a tertiary care metropolitan hospital. Race data was obtained from medical records. Only White, Black, and Latino children were included. Yes 1. Education of health care professionals on cultural competent care

2. Recruitment of more bilingual staff

3. Availability of 24-hour interpreter services in the emergency department and PICU

4. Translation of consent forms and educational materials for patients and families

5. Culturally sensitive end-of-life care discussions, with participation of palliative care services

6. Outreach efforts and contacts with the Latino community to remove barriers to health care access

7. Help from the city government and local health department for preventive services.
Implementation of a Reading Program in the Intensive Care Nursery Decreases Socio-economic and Racial Disparities in Parent-infant Verbal Interactions: A Pilot Model for Early Language Intervention Among High Risk Preterm Infants

Laura H. Rubinos
Parent self-reports of reading to their infant Conference abstract, 2018 Qualitative research,

funding sources not mentioned
Parents of infants less than 33 weeks gestational age at an academic level III NICU. No mention on how race was defined or how data were collected. No 1. Ongoing access to developmentally appropriate books through creation of an in-unit family lending library

2. Incorporation of parental educational resources and anticipatory guidance on importance of early literacy

3. Completion of a 10-question anonymous parent survey on admission, discharge, and during the developmental outpatient follow up visit.
Addressing Disparities in Mother’s Milk for VLBW Infants Through Statewide Quality Improvement†

Margaret G. Parker
Any and exclusive mother’s milk in the 24 hours before the initial disposition Peer-reviewed journal article, 2019 Quality improvement study,

funding from W.K. Kellogg Foundation
Very low birthweight infants or infants<30 weeks’ gestation. No mention on how race was defined. Yes Interventions on a variety of targets (parental education, early initiation of milk expression, inadequate continuation of milk, transition to direct breastfeeding, ‘other’, and racial ethnic disparities) were implemented. The use of these interventions varied between NICUs.

Statewide interventions on disparities included

1. Created 4 multicultural education handouts for families in 9 languages

2. Created 10 multicultural education videos for families, 5 in English and 5 in Spanish

3. Qualitative interviews with non-Hispanic black and Hispanic mothers
Targeting Bias to Reduce Disparities in End of Life Care (BRiDgE)*

Elizabeth Chuang
Ratio of clinician to patient speaking time Clinical trial registration, 2021 Randomized controlled trial,

funding from Montefiore Medical Center
Physicians who treat patients with serious illness. N/A, intervention implemented on providers Yes Training session to improve communication skills and reduce the effect of racial bias on clinician communication behavior based on transformational learning theory.
Improving racial disparities in unmet palliative care needs among intensive care unit family members with a needs-targeted app intervention: The ICUconnect randomized clinical trial*

Christopher E. Cox
Change in unmet palliative care needs measured by a scoring instrument between baseline and 3 days post-randomization Peer-reviewed journal article (protocol manuscript), 2021 Randomized controlled trial,

funding from National Institute on Minority Health and Health Disparities
Non-Hispanic Black or non-Hispanic White adults in the ICU for>= 48 hours. Race data were obtained from medical records. No ICUconnect mobile app which provides a digital infrastructure to guide the needs-focused interaction between family members and clinicians, promotes family engagement by providing a question coaching feature, and links families to reliable information on ICU practices and therapies
“Liquid Gold” Lactation Bundle and Breastfeeding Rates in Racially Diverse Mothers of Extremely Low-Birth-Weight Infants†

Maria Obaid
Exclusive mother’s own milk (MOM) diet at discharge Peer-reviewed journal article, 2021 Quality improvement study,

funding from the Kellogg Foundation and the Heckscher Foundation
Black, White, and Hispanic extremely low birthweight infants. Race data obtained from medical records. Yes 1. Staff education consisting of a 30-minute online training module with pre- and post-tests

2. Standardized daily skin-to-skin care protocol

3. COC within 24 hours of birth

4. Assistance with expression of breast milk within 6 hours postpartum

5. HM as the first enteral feed (MOM or PDHM)

6. Provision of exclusive HM diet supported by PDHM and HM fortifier (Prolact+H2 MF)

7. Daily rounds to assess lactation progress with a multidisciplinary team

8. Access to a certified LC in the L&D unit and for postpartum counseling

9. Provision of food trays for mothers when they visited their babies in the NICU

10. Elimination of all formula promotional materials

11. Assistance with obtaining a double electric breast pump, as mandated by the Affordable Care Act and covered by private and Medicaid insurance plans

Post-2016:

12. Implementation of HM cream (Prolact+CR)—an HM-derived caloric fortifier intended to supply more lipids and achieve adequate growth

13. Addition of a Spanish-speaking LC and increase in the full-time equivalent LC support to 2.0.
Improving Lactation Success in Black Mothers of Critically Ill Infants*

Leslie Parker
Number of participants acceptance of the intervention Clinical trial registration, 2021 Randomized controlled trial,

funding from University of Florida
Black mothers of newborn infants admitted to the NICU Race was self-reported. No A hands-free, wearable breast pump with an associated app that tracks pumping frequency and breast milk production to increase lactation success
Reducing Disparity in Receipt of Mother’s Own Milk in Very Low Birth Weight Infants (ReDiMOM)*

Aloka L. Patel
Receipt of MOM at NICU Discharge Clinical trial registration, 2021 Randomized controlled trial,

funding from National Institute on Minority Health and Health Disparities
Mothers and hospitalized infants in NICU. Only Black, Hispanic, and White patients were included. Race was self-reported. No 1. Hospital-grade electric smart breast pump for home use at no charge to the mother while the infant is in the NICU and the mother continues to pump

2. Free pickup of expressed MOM from home to transport to NICU 2–3 times per week during weekdays as needed

3. Receives payment for opportunity costs of pumping and handling milk at $18.50/day for each day that the mother pumps during her infant’s NICU stay
Mitigating Racial Disparities in Shared Decision Making in the Intensive Care Unit*

Deepshikha Ashana
Adoption rates of best practices for shared decision making with families of patients with acute respiratory failure Clinical trial registration, 2022 Non-randomized experimental study,

funding from National Heart, Lung and Blood Institute
Critically ill patients, non-Hispanic Black and White family members, and ICU physicians Race was self-reported. No Tip sheets containing best practices for shared decision making with diverse families
Mitigating structural racism to reduce inequities in sepsis outcomes: a mixed methods, longitudinal intervention study*

Erika L. Linnander
Early identification of sepsis as measured by time to antibiotic, in-hospital mortality, and 30-day hospital readmission Peer-reviewed journal article (protocol manuscript), 2022 Non-randomized experimental study,

funding from National Institute of General Medical Sciences to Yale University
8 U.S. health systems and surrounding communities Socially assigned race obtained from medical records/EHR. Yes A coalition-based leadership intervention that will include

three components:

1. a series of five semiannual virtual, cross-site forums

2. a series of four one-day workshops onsite at each hospital

3. a web-based platform to allow sites to share experiences and to serve as a repository for program resources.

*Current ongoing study

Interventions that continued to be implemented past the study period

More than half of studies (six studies, 55%) evaluated interventions for pediatric or newborn populations, with four (36%) studies targeting disparities in mother’s-own-milk feedings in the NICU [34,37,42,43]. The two remaining pediatric studies targeted ICU mortality and parent-infant verbal interactions in the NICU, respectively [44,45]. In the five studies of interventions to reduce disparities in adults with critical illness (45%), four studies focused on improving communication between patients and providers for end-of-life care and shared-decision making [3941,46]. Only one study targeted a clinical diagnosis, specifically sepsis [38]. Additionally, four out of five of the adult studies were ongoing at the time of analysis and had not yet reported any results [3841].

Most studies focused on increasing salutary health behaviors for all patients in practices that have been shown to have race-based differences [34,37,39,43,44,46]. For example, Obaid et al.’s primary objective in their “Liquid Gold” intervention was to increase mother’s own milk feedings in the NICU for all patients and their secondary aim was to evaluate the impact of the intervention on disparities between African American, White, and Hispanic mother-infant pairs [43]. In contrast, only Anand et al.’s study sought to resolve disparities in patient outcomes, in particular, reducing mortality in a Latino pediatric population [45].

Five studies (45%) had a pre-intervention period in which they assessed sources or mechanisms of disparities in the target outcome to inform the design of the intervention (Table 1) [37,38,41,43,45]. For instance, in Linnander et al.’s ongoing initiative to address inequities in sepsis outcomes, coalitions comprised of hospital leadership, patient advocacy representatives, and community organizations are participating in forums and workshops to identify which inequity processes are present in their health system and ways to address them. Coalitions will then implement the strategies and continually evaluate and adjust their solutions over a 2.5-year study period [38].

Linnander et al.’s study was also unique because it targeted organizational change to reduce racial and ethnic disparities [38]. While most interventions were not based on behavioral theories, Chuang’s clinical trial cited transformational learning theory as the basis of its intervention [41].

Lastly, studies varied in how they defined race and collected race data on participants (Table 1). Patient race was generally obtained from medical records or self-reported by patients; however, some studies did not specify a data collection method.

Taxonomy analysis

Our analysis of the intervention elements that appeared across studies yielded a taxonomy of 10 intervention components under five broad categories (Tables 2 and 3). The categories were Education (e.g., education of healthcare providers and/or education of patients and families), Communication (e.g., facilitated communication between providers and patients and increasing number of bilingual staff/and or interpreter services), Standardization (e.g., creating an automatic clinical decision support tool within the electronic medical record and standardizing a protocol for a specific healthcare process), Restructuring (e.g., financial and/or material resources provided to patient and families and restructuring patients’ environment), and Outreach (e.g., outreach efforts to the community and help from government services). Seven studies (64%) included Education elements, six (55%) Communication, three (27%) Standardization, five (45%) Resourcing, and only two (18%) Outreach (Table 3).

Table 2. Complex Intervention Components.

PEDIATRIC STUDIES ADULT STUDIES
DPI

Anand et al.
RPI

Rubinos et al.
LGL

Obaid et al.
ADM

Parker et al.
ILS

Parker et al.
RDR

Patel et al.
CIE

Mosenthal et al.
MSR

Linnander et al.
ICU

Cox et al.
TBR

Chuang et al.
MRD

Ashana et al.
Education Education of healthcare professionals X X X X X X
Education of patient & families X X X
Communication Facilitated communication between providers & patients & families X X X X X X
Increasing number of bilingual staff and/or interpreter services X X
Standardization Automatic clinical decision support tool within the electronic medical record X
Standardized and delivered a protocol for specific healthcare element X X X
Resourcing Financial and/or material resources provided to patient & families X X X X
Restructuring patients’ environment X X
Outreach Outreach efforts to the community X
Help from government services X X
LEGEND
DPI Decreased Pediatric ICU Mortality Intervention. Kanwaljeet J. S. Anand et al.
RPI Reading Program in the Intensive Care Nursery. Laura H. Rubinos et al.
LGL Liquid Gold Lactation Bundle in ELBW Infants. Maria Obaid et al.
ADM Addressing Disparities in Mother’s Milk Through Statewide QI. Margaret G. Parker et al.
ILS Improving Lactation Success in Black Mothers of Critically Ill Infants. Leslie Parker et al.
RDR Reducing Disparity in Receipt of Mother’s Own Milk (ReDiMOM). Aloka L. Patel et al.
CIE Communication Intervention in End of Life Care. Anne Mosenthal et al.
MSR Mitigating structural racism to reduce inequities in sepsis outcomes. Erika L. Linnander et al.
ICU The ICUconnect randomized clinical trial. Christopher E. Cox et al.
TBR Targeting Bias to Reduce Disparities in End-of-Life Care (BRiDgE). Elizabeth Chuang et al.
MRD Mitigating Racial Disparities in Shared Decision Making in the Intensive Care Unit. Deepshikha Ashana et al.

Table 3. Intervention Components.

Intervention Category Number of unique studies (n = 11)
Education 7 (64%)
 Education of healthcare professionals 6 (55%)
 Education of patient and families 3 (27%)
Communication 6 (55%)
 Facilitated communication between providers and patients and families 7 (64%)
 Increasing number of bilingual staff and/or interpreter services 2 (18%)
Standardization 3 (27%)
 Automatic clinical decision support tool within the electronic medical record 1 (9%)
 Standardized and delivered a protocol for specific healthcare element 3 (27%)
Resourcing 5 (45%)
 Financial and/or material resources provided to patient and families 4 (36%)
 Restructuring patients’ environment 2 (18%)
Outreach 2 (18%)
 Outreach efforts to the community 1 (9%)
 Help from government services 2 (18%)

The characterization of intervention components captured the multifactorial approaches investigators used to address disparities (Tables 2 and 3). Six studies (55%) employed complex “bundled” interventions, which combined two or more intervention components to achieve a desired outcome (Table 2) [37,40,4346]. The pediatric studies combined more intervention components than adult studies. The four pediatric studies with complex interventions (36%) had a range of three to seven components in their bundles [37,4345]. In contrast, the two adult studies (18%) evaluating complex interventions each included two intervention components [40,46]. The adult studies also did not include any Standardization, Resourcing, or Outreach elements. Across studies, the most commonly deployed intervention component was education of healthcare professionals (six studies, 55%) and facilitated communication between providers and patients and families (six studies, 55%), followed by financial and/or material resources provided to patient and families (four studies, 36%).

Discussion

In this scoping review, we described and analyzed existing interventions to reduce racial or ethnic disparities in critical care settings. Despite decades of evidence identifying racial and ethnic disparities in ICU care [1], our findings suggest that very few interventions to address these recognized disparities in the ICU have been systematically evaluated. After searching databases of peer-reviewed articles, conference abstracts, and ongoing study registries, our review yielded only 11 intervention studies. Previous systematic reviews suggest that comparatively more attention has been paid to identifying disparities in critical care than to evaluating interventions to reduce disparities. To illustrate, Soto et al. and McGowan et al. found 38 and 25 studies, respectively, that identified disparities in adult ICU care [1,2]. Sigurdson et al. found 41 studies that identified disparities in neonatal ICU care [3]. Soto et al. noted also that no studies had yet aimed to reduce disparities at the time of publishing in 2013, and similarly, the other two groups did not describe intervention studies [13].

Kilbourne et al. organized health disparities research into three phases: detecting disparities, understanding the underlying mechanism of a disparity, and designing interventions to reduce and eliminate disparities [47]. The relative scarcity of intervention-oriented studies found in our study compared to the large number of observational studies found in prior reviews demonstrates that ICU disparities research has largely remained in the detection phase. Though research focused on detecting disparities has demonstrated significant differences in ICU care and outcomes by race and ethnicity, interventions designed to reduce or eliminate disparities remain troublingly rare. Even using a broad definition of intervention, we found only 11 intervention studies aiming to reduce racial or ethnic disparities in outcomes or delivery of critical care, with eight studies being from the last five years. These include reports for six ongoing randomized, controlled trials (RCTs) of interventions to reduce disparities in critical care settings [34,3842].

One possible explanation for this stall is that researchers have yet to closely study mechanisms underlying disparities in critical care outcomes. Many studies did not describe the interventions they evaluated as designed around an empirically grounded theory or formative mechanistic research linking a particular barrier (e.g., clinician knowledge) to a specific patient outcome (e.g., increased rates of infants receiving mother’s own milk). Though some investigators designed interventions in response to observations during a pre-intervention period, assessments from the pre-study period and rationale for the associated intervention component were not consistently reported. Most studies clearly identified disparities and then proposed a bundle of intervention components that might reduce disparities through multiple pathways. For example, in Anand et al.’s study to reduce mortality of Latino PICU patients, investigators conducted a pre-intervention assessment and subsequently employed a bundle intervention, but did not elaborate the reasoning behind each intervention component [45]. Consequently, it is difficult to distinguish effective intervention components from ineffective components. Moreover, interventions designed using behavior change frameworks are more effective than interventions designed without frameworks [48,49]. Only Chuang’s study cited a behavioral theory for the basis of the intervention [41]. Future research should review the state of knowledge regarding mechanisms driving critical care disparities to develop theoretically and empirically grounded interventions.

Our scoping review did not seek to assess the quality of study designs because we aimed to survey current knowledge on reducing disparities in the ICU and, as our review demonstrates, research to reduce disparities is at an early state [28]. There is a breadth of study types among the included literature, including RCTs, pre-post studies, and QI initiatives (Table 1). Thus, it would not have been reasonable to evaluate study quality. It is, however, notable that most studies relied on pre-post designs rather than RCT designs. There are many barriers to carrying out randomized, controlled evaluations of interventions to reduce disparities. Most interestingly, many interventions to reduce disparities are organizational and must be delivered at the level of the ICU or the hospital rather than at the level of the patient. Stepped-wedge and other cluster-randomized, controlled trials are appropriate for evaluating such interventions, but they are resource-intensive. Nonetheless, more than half of the studies included in our analysis are currently ongoing trials, which suggests that controlled trials of interventions to reduce inequalities in critical care are growing rapidly.

We found that many of the interventions included in this review focused on standardizing delivery of care with the aim of reducing disparities in patient outcomes. Structured care processes can reduce bias in care and clinical decision-making. However, the instruments and measures used to deliver standardized care may themselves need to be re-evaluated to avoid re-inscribing structural bias. For example, the incorporation of race into the equation of estimated glomerular filtration rate (eGFR) is debated because the formula assigns higher eGFR values to Black patients without substantial empirical data. Inflating the kidney function of Black patients affects medication doses and restricts patients from receiving timely nephrology referrals, participating in clinical trials, and obtaining life-saving kidney transplants [50]. Due to these implications, many health institutions now mandate calculation of eGFR using a formula without a race parameter. In addition, studies have also shown that pulse oximeters produce biased measures of oxygen saturation for patients with darker skin tone [51]. Care processes that make use of biased instruments may worsen quality of care and endanger minority patients even when clinicians themselves do not exercise bias in clinical decision-making.

We also found that the adult interventions to reduce disparities in adult critical care used a relatively narrow range of strategies. Interventions for adult critical care focused on educating providers regarding culturally competent care and facilitating communication with patients. In contrast, the studies seeking to reduce disparities in pediatric critical care employed more intervention types, including strategies that extended beyond the ICU such as Outreach and Resourcing to address structural sources of disparities. This difference may be attributed to the fact that parents or other adult guardians are typically surrogate decision makers for pediatric patients, and so pediatric intensivists are more confronted by their patients’ social contexts. The more varied approach of the pediatric studies highlights possible new approaches for interventions in adult critical care.

Finally, methodology for collecting race and ethnicity data was not consistently reported across studies. The American Medical Association guidance for reporting race and ethnicity recommends that authors report in their Methods an explanation describing both how race and ethnicity data were collected and why they were collected in this way [52]. Future studies should report the method and rationale for identifying the race and ethnicity of participants.

Our review possessed several strengths. We systematically searched a wide variety of databases to identify both completed and ongoing research, as well as research that may have been carried out but never reported in peer-reviewed venues. Furthermore, our approach to extraction of intervention targets and components for each study enabled us to identify the most common strategies across a broad range of interventions to reduce disparities. Finally, our methods relied on multiple independent reviewers to improve rigor and reliability.

Our scoping review also had some limitations. First, we were unable to identify ongoing studies not registered in Clinicaltrials.gov or NIH RePORTER. Privately funded studies or quality improvement initiatives may be missing from our analysis if they were not reported in a peer-reviewed journal. Second, due to the small number of studies and our objective of providing a comprehensive review of all critical care interventions, we included interventions targeting age-diverse populations, from neonates to adults. The NICU is a unique care setting and the barriers and facilitators to equal care delivery and outcomes in this setting may differ substantially from those in pediatric or adult critical care. In addition, our review only included studies conducted in the United States, so interventions employed outside of the U.S. or published in non-English may have been overlooked. We did not include non-U.S studies because the U.S. has a distinct landscape of racial and ethnic disparities in healthcare, shaped by its history, policies, and sociocultural dynamics. Studies outside the U.S. would likely address disparities within different sociopolitical and healthcare contexts, making direct comparisons challenging [25,5355].

Conclusion

Despite the widespread recognition of racial and ethnic disparities in critical care, there is little evidence of rigorous efforts to address them through interventions. This is the first study to comprehensively examine interventions addressing racial and ethnic disparities in critical care processes and patient outcomes. Of the few interventions that have been evaluated, many did not describe the rationale or targeted disparity mechanism for their intervention design. Interventions should be developed based on theories that address recognized mechanisms of disparities. There is a need for randomized, controlled evaluations of theory-informed interventions to reduce racial and ethnic disparities in critical care.

Supporting information

S1 Checklist. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist.

(DOCX)

pone.0336922.s001.docx (84.8KB, docx)
S1 Database. Database Search Strategies.

(DOCX)

pone.0336922.s002.docx (18.6KB, docx)
S1 Text. Studies Excluded in Full-Text Review.

(DOCX)

pone.0336922.s003.docx (30.4KB, docx)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.McGowan SK, Sarigiannis KA, Fox SC, Gottlieb MA, Chen E. Racial Disparities in ICU Outcomes: A Systematic Review. Crit Care Med. 2022;50(1):1–20. doi: 10.1097/CCM.0000000000005269 [DOI] [PubMed] [Google Scholar]
  • 2.Soto GJ, Martin GS, Gong MN. Healthcare disparities in critical illness. Crit Care Med. 2013;41(12):2784–93. doi: 10.1097/CCM.0b013e3182a84a43 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sigurdson K, Mitchell B, Liu J, Morton C, Gould JB, Lee HC, et al. Racial/Ethnic Disparities in Neonatal Intensive Care: A Systematic Review. Pediatrics. 2019;144(2):e20183114. doi: 10.1542/peds.2018-3114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bosch NA, Fantasia KL, Modzelewski KL, Alexanian SM, Walkey AJ. Racial Disparities in Guideline-Concordant Insulin Infusions during Critical Illness. Ann Am Thorac Soc. 2021;18(2):368–71. doi: 10.1513/AnnalsATS.202007-893RL [DOI] [PubMed] [Google Scholar]
  • 5.Chan PS, Krumholz HM, Nichol G, Nallamothu BK, American Heart Association National Registry of Cardiopulmonary Resuscitation I. Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med. 2008;358(1):9–17. [DOI] [PubMed] [Google Scholar]
  • 6.Mayr FB, Yende S, D’Angelo G, Barnato AE, Kellum JA, Weissfeld L, et al. Do hospitals provide lower quality of care to black patients for pneumonia? Crit Care Med. 2010;38(3):759–65. doi: 10.1097/CCM.0b013e3181c8fd58 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shaw JJ, Santry HP. Who gets early tracheostomy? Evidence of unequal treatment at 185 academic medical centers. Chest. 2015;148(5):1242–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Brown CE, Engelberg RA, Sharma R, Downey L, Fausto JA, Sibley J, et al. Race/Ethnicity, Socioeconomic Status, and Healthcare Intensity at the End of Life. J Palliat Med. 2018;21(9):1308–16. doi: 10.1089/jpm.2018.0011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Armstrong-Hough M, Lin P, Venkatesh S, Ghous M, Hough CL, Cook SH, et al. Ethnic Disparities in Deep Sedation of Patients with Acute Respiratory Distress Syndrome in the United States: Secondary Analysis of a Multicenter Randomized Trial. Ann Am Thorac Soc. 2024;21(4):620–6. doi: 10.1513/AnnalsATS.202307-600OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Barnato AE, Alexander SL, Linde-Zwirble WT, Angus DC. Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med. 2008;177(3):279–84. doi: 10.1164/rccm.200703-480OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Erickson SE, Shlipak MG, Martin GS, Wheeler AP, Ancukiewicz M, Matthay MA, et al. Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med. 2009;37(1):1–6. doi: 10.1097/CCM.0b013e31819292ea [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Cooke CR, Erickson SE, Eisner MD, Martin GS. Trends in the incidence of noncardiogenic acute respiratory failure: the role of race. Crit Care Med. 2012;40(5):1532–8. doi: 10.1097/CCM.0b013e31824518f2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Heit JA, Beckman MG, Bockenstedt PL, Grant AM, Key NS, Kulkarni R, et al. Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol. 2010;85(7):467–71. doi: 10.1002/ajh.21735 [DOI] [PubMed] [Google Scholar]
  • 14.White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost. 2005;93(2):298–305. doi: 10.1160/TH04-08-0506 [DOI] [PubMed] [Google Scholar]
  • 15.White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123 Suppl 4:S11-7. doi: 10.1016/S0049-3848(09)70136-7 [DOI] [PubMed] [Google Scholar]
  • 16.Guner YS, Friedlich P, Wee CP, Dorey F, Camerini V, Upperman JS. State-based analysis of necrotizing enterocolitis outcomes. J Surg Res. 2009;157(1):21–9. doi: 10.1016/j.jss.2008.11.008 [DOI] [PubMed] [Google Scholar]
  • 17.Qureshi AI, Adil MM, Shafizadeh N, Majidi S. A 2-fold higher rate of intraventricular hemorrhage-related mortality in African American neonates and infants. J Neurosurg Pediatr. 2013;12(1):49–53. doi: 10.3171/2013.4.PEDS12568 [DOI] [PubMed] [Google Scholar]
  • 18.Carome K, Rahman A, Parvez B. Exclusive human milk diet reduces incidence of severe intraventricular hemorrhage in extremely low birth weight infants. J Perinatol. 2021;41(3):535–43. doi: 10.1038/s41372-020-00834-5 [DOI] [PubMed] [Google Scholar]
  • 19.Vohr BR, Poindexter BB, Dusick AM, McKinley LT, Wright LL, Langer JC, et al. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics. 2006;118(1):e115-23. doi: 10.1542/peds.2005-2382 [DOI] [PubMed] [Google Scholar]
  • 20.Rahman A, Kase JS, Murray YL, Parvez B. Neurodevelopmental Outcome of Extremely Low Birth Weight Infants Fed an Exclusive Human Milk Diet Is Not Affected by Growth Velocity. Breastfeed Med. 2020;15(6):362–9. doi: 10.1089/bfm.2019.0214 [DOI] [PubMed] [Google Scholar]
  • 21.Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O’Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol. 2007;27(7):428–33. doi: 10.1038/sj.jp.7211758 [DOI] [PubMed] [Google Scholar]
  • 22.Patel AL, Johnson TJ, Robin B, Bigger HR, Buchanan A, Christian E, et al. Influence of own mother’s milk on bronchopulmonary dysplasia and costs. Arch Dis Child Fetal Neonatal Ed. 2017;102(3):F256–61. doi: 10.1136/archdischild-2016-310898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med. 2003;157(1):66–71. doi: 10.1001/archpedi.157.1.66 [DOI] [PubMed] [Google Scholar]
  • 24.Hospitalization and Death by Race/Ethnicity: Centers for Disease Control and Prevention. [updated March 25, 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html [Google Scholar]
  • 25.Romano SD, Blackstock AJ, Taylor EV, El Burai Felix S, Adjei S, Singleton CM. Trends in racial and ethnic disparities in COVID-19 hospitalizations, by region - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(15):560–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Visintini S. 2017. [cited 2021]. Available from: https://www.sarahvisintini.ca/organizing-your-systematic-review-review-protocol-template/ [Google Scholar]
  • 27.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119–26. doi: 10.11124/JBIES-20-00167 [DOI] [PubMed] [Google Scholar]
  • 29.Braveman P. Health disparities and health equity: concepts and measurement. Annu Rev Public Health. 2006;27:167–94. doi: 10.1146/annurev.publhealth.27.021405.102103 [DOI] [PubMed] [Google Scholar]
  • 30.Braveman P, Gruskin S. Defining equity in health. J Epidemiol Community Health. 2003;57(4):254–8. doi: 10.1136/jech.57.4.254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation. [Google Scholar]
  • 32.Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Johnson TJ, Meier PP, Schoeny ME, Bucek A, Janes JE, Kwiek JJ, et al. Study protocol for reducing disparity in receipt of mother’s own milk in very low birth weight infants (ReDiMOM): a randomized trial to improve adherence to sustained maternal breast pump use. BMC Pediatr. 2022;22(1):27. doi: 10.1186/s12887-021-03088-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Patel AL, Johnson TJ. Reducing Disparity in Receipt of Mother’s Own Milk in Very Low Birth Weight Infants (ReDiMOM) ClinicalTrials.gov: National Library of Medicine (US). [updated August 25, 2021. NCT04540575]. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT04540575 [Google Scholar]
  • 35.Corl K, Levy M, Phillips G, Terry K, Friedrich M, Trivedi AN. Racial and ethnic disparities in care following the New York State sepsis initiative. Health Affairs. 2019;38(7):1119–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Parker MG, Drainoni M-L, Garg A. Implementing a Social Determinants of Health Screening and Referral Care Model in the Neonatal Intensive Care Unit NIH RePORTER. 2023. Available from: https://reporter.nih.gov/search/gtTnot0YB0y7dvNOzWChsQ/project-details/10689267#details [Google Scholar]
  • 37.Parker MG, Burnham LA, Melvin P, Singh R, Lopera AM, Belfort MB, et al. Addressing Disparities in Mother’s Milk for VLBW Infants Through Statewide Quality Improvement. Pediatrics. 2019;144(1):e20183809. doi: 10.1542/peds.2018-3809 [DOI] [PubMed] [Google Scholar]
  • 38.Linnander EL, Ayedun A, Boatright D, Ackerman-Barger K, Morgenthaler TI, Ray N, et al. Mitigating structural racism to reduce inequities in sepsis outcomes: a mixed methods, longitudinal intervention study. BMC Health Serv Res. 2022;22(1):975. doi: 10.1186/s12913-022-08331-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Cox CE, Riley IL, Ashana DC, Haines K, Olsen MK, Gu J, et al. Improving racial disparities in unmet palliative care needs among intensive care unit family members with a needs-targeted app intervention: The ICUconnect randomized clinical trial. Contemp Clin Trials. 2021;103:106319. doi: 10.1016/j.cct.2021.106319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ashana DC. Racial disparities in shared decision making for patients with acute respiratory failure NIH RePORTER [updated September 1, 2022. 1K23HL164968-01}. Available from: https://reporter.nih.gov/search/ug-EiAYxpUaVhA7jPVRSjg/project-details/10506137 [Google Scholar]
  • 41.Chuang E. Targeting Bias to Reduce Disparities in End of Life Care (BRiDgE) ClinicalTrials.gov: National Library of Medicine (US). [updated December 21, 2021. NCT05165888]. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT05165888 [Google Scholar]
  • 42.Parker L. Improving Lactation Success in Black Mothers of Critically Ill Infants ClinicalTrials.gov: National Library of Medicine (US). [updated December 22, 2022. NCT05147987]. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT05147987 [Google Scholar]
  • 43.Obaid M, Igawa T, Maxwell A, Murray YL, Rahman A, Aboudi D, et al. “Liquid Gold” Lactation Bundle and Breastfeeding Rates in Racially Diverse Mothers of Extremely Low-Birth-Weight Infants. Breastfeed Med. 2021;16(6):463–70. doi: 10.1089/bfm.2020.0322 [DOI] [PubMed] [Google Scholar]
  • 44.Rubinos LH, Brown M, Christ L, Bahrami L, Ziolkowski K, Hurt H. Implementation of a Reading Program in the Intensive Care Nursery Decreases Socio-economic and Racial Disparities in Parent-infant Verbal Interactions: A Pilot Model for Early Language Intervention Among High Risk Preterm Infants. Pediatrics. 2018;141(1_MeetingAbstract):529–529. doi: 10.1542/peds.141.1ma6.529 [DOI] [Google Scholar]
  • 45.Anand KJS, Sepanski RJ, Giles K, Shah SH, Juarez PD. Pediatric intensive care unit mortality among Latino children before and after a multilevel health care delivery intervention. JAMA Pediatr. 2015;169(4):383–90. doi: 10.1001/jamapediatrics.2014.3789 [DOI] [PubMed] [Google Scholar]
  • 46.Mosenthal A, Murphy P, Lamba S, Compton S, Zitter J. Impact of a Communication Intervention Around Goals of Care on Racial Disparities in End-of-Life Care in the Intensive Care Unit. J Pain Symp Manag. 2010;39(2):342–3. doi: 10.1016/j.jpainsymman.2009.11.260 [DOI] [Google Scholar]
  • 47.Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96(12):2113–21. doi: 10.2105/AJPH.2005.077628 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Glanz K, Bishop DB. The role of behavioral science theory in development and implementation of public health interventions. Annu Rev Public Health. 2010;31:399–418. doi: 10.1146/annurev.publhealth.012809.103604 [DOI] [PubMed] [Google Scholar]
  • 49.Tabak RG, Khoong EC, Chambers DA, Brownson RC. Bridging research and practice: models for dissemination and implementation research. Am J Prev Med. 2012;43(3):337–50. doi: 10.1016/j.amepre.2012.05.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Eneanya ND, Yang W, Reese PP. Reconsidering the Consequences of Using Race to Estimate Kidney Function. JAMA. 2019;322(2):113–4. doi: 10.1001/jama.2019.5774 [DOI] [PubMed] [Google Scholar]
  • 51.Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial Bias in Pulse Oximetry Measurement. New England J Med. 2020;383(25):2477–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Flanagin A, Frey T, Christiansen SL, Committee AMAM o S. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA. 2021;326(7):621–7. [DOI] [PubMed] [Google Scholar]
  • 53.Yearby R, Clark B, Figueroa JF. Structural Racism In Historical And Modern US Health Care Policy. Health Aff (Millwood). 2022;41(2):187–94. doi: 10.1377/hlthaff.2021.01466 [DOI] [PubMed] [Google Scholar]
  • 54.Fraiman YS, Litt JS, Davis JM, Pursley DM, Pediatric Policy Council. Racial and ethnic disparities in adult COVID-19 and the future impact on child health. Pediatr Res. 2021;89(5):1052–4. doi: 10.1038/s41390-021-01377-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Adler NE, Rehkopf DH. U.S. disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health. 2008;29:235–52. doi: 10.1146/annurev.publhealth.29.020907.090852 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

De-Chih Lee

21 Jan 2025

Dear Dr. Ge,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 07 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

De-Chih Lee, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments :

Please make minor revisions based on the comments of the two reviewers.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: There are two limitations of this study that have not been discussed:

1) "We limited the scope of our review to the United States to enhance comparability of studies."

2) "Our scoping review did not seek to assess the quality of study designs because, as our review demonstrates, research to reduce disparities is at an early stage."

These two inclusion criteria could have limited external validity and increased the risk of bias. These two aspects should be highlighted in the discussion, and limitations regarding interpretation should be addressed.

Even though inequity has been included as a search term, it has not been discussed, and references to use this perspective are missing.

Reviewer #2: Thank you for conducting this incredibly valuable work, and for the opportunity to review it for the team. My expertise lies in knowledge synthesis methodology generally and search methodology specifically, so that is where I will be focusing my feedback.

Data availability: this paper has good advice for what kind of data could/should be shared for knowledge syntheses. While you provide a lot, I think there's some "behind the curtain" stuff that could be shared, eg. templates, rough extraction data, list of full-text references that didn't meet inclusion, etc.

Page MJ, Nguyen PY, Hamilton DG, Haddaway NR, Kanukula R, Moher D, et al. Data and code availability statements in systematic reviews of interventions were often missing or inaccurate: a content analysis. J Clin Epidemiol [Internet]. 2022;147:1–10. Available from: https://doi.org/10.1016/j.jclinepi.2022.03.003

Methods:

- the PRISMA you cite is for systematic reviews, please follow/cite the Scoping Review extension

- technically PRISMA is a reporting guideline only, not conduct. For conduct see JBI and Arksey & O'Malley.

- on page 4 you mention journals, conference abstracts and clinical trial registries, change subjects, and then report on the handsearching again - consider tightening this section up for clarity, and potentially making use of tables in the supplementary files (e.g. source searched, dates, keywords/method used to search, etc)

- does it make sense to report two database search approaches if ultimately you conducted the broader search anyway? I feel like this is eating up potential word count for results/discussion

- (pg.6) PROSPERO is a systematic review protocol registry, does the team mean PRISMA?

- please review PRISMA-S and report search strategies accordingly. They should be provided in full as run in the supplemental files. For example from how the searches are presented, it's hard to know if subject headings were searched in addition to keywords, what fields were searched, etc.

- I'm a little concerned that the search may be overly simplistic (see for example the racial/ethnic search filters available here: https://sites.google.com/a/york.ac.uk/issg-search-filters-resource/home/population-specific)

Results:

- I really like the way the team chose to break down results. It's very clear and the groupings are helpful for getting a bird's eye view.

- your tables are really clear and easy to read

Discussion:

- the Kilbourne phases is a helpful breakdown

- I think it's important here to emphasize that these are only American findings, and there may be different levels of development/interrogation of mechanism of action in other jurisdictions that are similar to the US (e.g. Canada, UK, Australia), or just globally, since every country has their own racial minorities. It would be helpful to contextualize your findings with the rest of the world, or if that's not feasible, frequently emphasize that these findings only relate to the US and not all of critical care literature.

- quality appraisal in scoping reviews are not common because they're intended to answer different questions. It might be simpler to just cite JBI here rather than getting into breadth of study designs.

- I think your decision to limit to US-only is also a limitation, since NICUs/ICUs are pretty structured settings (it's not like we're comparing public health initiatives or something really nebulous) and could have had a lot to offer and provided richer context of where the literature is right now.

Final thoughts: This was a really well written and thoughtful paper, and provides some very rich feedback for researchers in this field moving forward. I'm a bit concerned about the robustness of the search, especially if subject headings weren't used, as that is standard practice for knowledge synthesis searching. This would be easy enough to fix, though it would take this from a minor revisions to a major one since it would require additional screening, etc.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Airton Tetelbom Stein

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

PLoS One. 2025 Nov 25;20(11):e0336922. doi: 10.1371/journal.pone.0336922.r002

Author response to Decision Letter 1


7 Mar 2025

Reviewer #1: There are two limitations of this study that have not been discussed:

1) "We limited the scope of our review to the United States to enhance comparability of studies."

2) "Our scoping review did not seek to assess the quality of study designs because, as our review demonstrates, research to reduce disparities is at an early stage."

These two inclusion criteria could have limited external validity and increased the risk of bias. These two aspects should be highlighted in the discussion, and limitations regarding interpretation should be addressed.

We have added both these limitations to the Discussion. We now also elaborate on the decision to limit our literature search to the United States because the U.S. has a distinct landscape of racial and ethnic disparities in healthcare shaped by its history, policies, and sociocultural dynamics (Lines 369-375).

Even though inequity has been included as a search term, it has not been discussed, and references to use this perspective are missing.

In Methods, we now describe how “inequity” is distinct from “inequality” or “disparity” and cite references for these distinctions. We then justify inclusion of “inequity” and “inequities” in our search strategy to capture all articles relevant to disparity research (Lines 124-126).

Reviewer #2: Thank you for conducting this incredibly valuable work, and for the opportunity to review it for the team. My expertise lies in knowledge synthesis methodology generally and search methodology specifically, so that is where I will be focusing my feedback.

Data availability: this paper has good advice for what kind of data could/should be shared for knowledge syntheses. While you provide a lot, I think there's some "behind the curtain" stuff that could be shared, eg. templates, rough extraction data, list of full-text references that didn't meet inclusion, etc.

Page MJ, Nguyen PY, Hamilton DG, Haddaway NR, Kanukula R, Moher D, et al. Data and code availability statements in systematic reviews of interventions were often missing or inaccurate: a content analysis. J Clin Epidemiol [Internet]. 2022;147:1–10. Available from: https://doi.org/10.1016/j.jclinepi.2022.03.003.

We address this by adding new supplementary materials, including the PRISMA-S checklist and a list of the papers excluded during full-text review (see Supplementary Materials 1 and 3).

Methods:

- the PRISMA you cite is for systematic reviews, please follow/cite the Scoping Review extension

- technically PRISMA is a reporting guideline only, not conduct. For conduct see JBI and Arksey & O'Malley.

Thank you; we have clarified the citation of the PRISMA reporting guideline used. We have also clarified the language in the Methods section to clarify that we used the PRISMA-S guideline for reporting our procedures and results, not for guiding our procedures (Lines 91-94).

- on page 4 you mention journals, conference abstracts and clinical trial registries, change subjects, and then report on the handsearching again - consider tightening this section up for clarity, and potentially making use of tables in the supplementary files (e.g. source searched, dates, keywords/method used to search, etc).

We created Supplementary Material 2 which details the search strategy formatted to query each database, how many articles each database yielded, and further details on the search terms and yields of the hand search portion of our review. We also clarified the language in this paragraph (Lines 106-107).

- does it make sense to report two database search approaches if ultimately you conducted the broader search anyway? I feel like this is eating up potential word count for results/discussion.

We included both search strategies to highlight how we sought to specifically search for interventions targeting health disparities in critical care. As our study was a scoping review and we aimed to survey all available knowledge on our subject of interest, we conducted the broad database search last to ensure our search results were comprehensive.

- (pg.6) PROSPERO is a systematic review protocol registry, does the team mean PRISMA?

We indeed meant PRISMA-S. We replaced PROSPERO with PRISMA in the manuscript. Thank you for finding this error (Line 149).

- please review PRISMA-S and report search strategies accordingly. They should be provided in full as run in the supplemental files. For example from how the searches are presented, it’s hard to know if subject headings were searched in addition to keywords, what fields were searched, etc.

We now include the PRISMA-S checklist and all search strategies in the supplementary material (see Supplementary Material 1).

- I'm a little concerned that the search may be overly simplistic (see for example the racial/ethnic search filters available here: https://sites.google.com/a/york.ac.uk/issg-search-filters-resource/home/population-specific).

We agree that this is a valid concern given the complexity of defining and capturing racial and ethnic disparities in healthcare research. However, our approach was guided by our specific research objective: to identify interventions addressing racial and ethnic disparities in critical care, rather than disparities affecting a particular group. Because of this broad scope, we designed a search strategy that was inclusive of all relevant studies, regardless of the population examined. To ensure methodological rigor, we collaborated with a research librarian, Hope Lappen, MLIS, MS, who has expertise in systematic and scoping review search strategies. Her input refined our search strategy, ensuring that it captured the breadth of relevant literature without being overly narrow or missing key studies.

Results:

- I really like the way the team chose to break down results. It's very clear and the groupings are helpful for getting a bird's eye view.

- your tables are really clear and easy to read

Thank you for these kind comments on our Results and Tables.

Discussion:

- the Kilbourne phases is a helpful breakdown

- I think it's important here to emphasize that these are only American findings, and there may be different levels of development/interrogation of mechanism of action in other jurisdictions that are similar to the US (e.g. Canada, UK, Australia), or just globally, since every country has their own racial minorities. It would be helpful to contextualize your findings with the rest of the world, or if that's not feasible, frequently emphasize that these findings only relate to the US and not all of critical care literature.

We now emphasize that these findings are specific to the US and discuss the rationale for and limitations inherent in this approach (Lines 369-375).

- quality appraisal in scoping reviews are not common because they're intended to answer different questions. It might be simpler to just cite JBI here rather than getting into breadth of study designs.

Thank you for this suggestion; we now cite JBI to support this point (Line 302-303, Reference #28).

- I think your decision to limit to US-only is also a limitation, since NICUs/ICUs are pretty structured settings (it's not like we're comparing public health initiatives or something really nebulous) and could have had a lot to offer and provided richer context of where the literature is right now.

We now address the US-only inclusion criterion as a limitation in the Discussion.

Final thoughts: This was a really well written and thoughtful paper, and provides some very rich feedback for researchers in this field moving forward. I'm a bit concerned about the robustness of the search, especially if subject headings weren't used, as that is standard practice for knowledge synthesis searching. This would be easy enough to fix, though it would take this from a minor revisions to a major one since it would require additional screening, etc.

We would like to thank the reviewer for their insights and suggestions. The subject headings of literature were included in the search; this is now evident in the supplementary material detailing all searches (Supplementary Material 2) and it is now mentioned in the Methods section (Lines 106-107).

Attachment

Submitted filename: PLOS ONE Response to Reviewers_final.docx

pone.0336922.s005.docx (129.3KB, docx)

Decision Letter 1

De-Chih Lee

12 Apr 2025

Dear Dr. Ge,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 27 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

De-Chih Lee, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments :

Please make major revisions based on the review by two reviewers. Authors are asked to review the questions raised by the first reviewer to find if any critical literature has been missed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: N/A

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: No

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

Reviewer #3: Yes

**********

Reviewer #2: Thank you very much for all the work you have put into revising this paper, already it is stronger!

Unfortunately, now that I can see the searches in full, they are not sufficiently robust to be published as part of a scoping review. The Web of Science search is fine as the database doesn't have subject headings, but PubMed, Embase and CINAHL all have subject headings that would directly apply to this topic (e.g. in PubMed: Ethnicity, Minority Groups, Race Factors, Racial Groups), and the use of both keywords and subject headings is recommended by all major synthesis bodies (Cochrane, JBI, etc). Some of these databases have mapping capabilites but they are not robust - when I tested the racial component of the search in PubMed and CINAHL the results were different with subject headings included. Here is an example of a broad race/ethnicity search for context (though it is for Ovid Medline): https://hsls.libguides.com/Ovid-Medline-search-filters/race-ethnicity#s-lg-box-32796073. The same goes for disparities, ICU, and to a lesser extent, quality improvement. All aspects of the search should have subject headings as well as keywords where applicable subject headings exist.

In addition to the fact that the search does not make use of subject headings, there are still numerous terms that I would expect to see in each category: minority group*, people/person/communit*/children/men/women of color/colour, equity, unequit*, unequal*, inadequat*, underserv*, disadvant*, depriv*, disproport*, bias, discriminat*, prejud*, racism, racist, potentially barrier*, critically ill, ECMO and ARDS acronyms spelled out, septic, potentially facilitat*

I recommend the team revisit the searches with the librarian with an eye for subject headings and keywords (which you could limit to title/abstract only to keep numbers reasonable, as this is common practice for reviews), overlap this with what you've already screened and screen the difference.

Reviewer #3: Very important and necessary contribution. I appreciated reading the in-depth description of how the team developed the taxonomy as well as how you decided to include or exclude studies (i.e. studies that had the 'wrong intervention').

Please reframe the next steps (i.e. instead of calling for randomized control trials since it is unethical to perform this type of research in the social sciences by exposing a group to poor conditions for the purpose of investigation). Also, scoping reviews are not designed to assess the quality of research but the breadth so please update the statement that you conducted a rigorous evaluation of interventions aimed at eliminating disparities in critical care.

The abstract notes there were 86 studies that underwent full text review but the narrative lists that number as 75. Which was it?

Since you cite the AMA's guidance on the need for the reviewed studies to define and frame race, will you elucidate the reason that your research team did not decide to also follow the AMA guidance on the reporting of race in your narrative (i.e. lowercase the 'w' in white): https://www.ama-assn.org/system/files/ama-aamc-equity-guide.pdf

Otherwise, well done.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Nov 25;20(11):e0336922. doi: 10.1371/journal.pone.0336922.r004

Author response to Decision Letter 2


3 Jun 2025

Emily Chenette, PhD

Editor-in-Chief

PLOS One

June 2, 2025

Dear Dr. Chenette and the PLOS One Editorial Team,

Thank you for your consideration of our revised manuscript “Interventions to improve racial and ethnic equity in critical care: A scoping review”. We are grateful for the reviewers’ thoughtful and constructive feedback. We have considered each of their comments and have made the necessary revisions. Below, we provide a point-by-point response to the reviewers’ concerns. We believe these revisions have improved the rigor and impact of our manuscript. We hope that our revised manuscript now meets the standards for publication in PLOS One and look forward to your assessment.

Reviewer #2: Thank you very much for all the work you have put into revising this paper, already it is stronger!

Comment: Unfortunately, now that I can see the searches in full, they are not sufficiently robust to be published as part of a scoping review. The Web of Science search is fine as the database doesn't have subject headings, but PubMed, Embase and CINAHL all have subject headings that would directly apply to this topic (e.g. in PubMed: Ethnicity, Minority Groups, Race Factors, Racial Groups), and the use of both keywords and subject headings is recommended by all major synthesis bodies (Cochrane, JBI, etc). Some of these databases have mapping capabilites but they are not robust - when I tested the racial component of the search in PubMed and CINAHL the results were different with subject headings included. Here is an example of a broad race/ethnicity search for context (though it is for Ovid Medline): https://hsls.libguides.com/Ovid-Medline-search-filters/race-ethnicity#s-lg-box-32796073. The same goes for disparities, ICU, and to a lesser extent, quality improvement. All aspects of the search should have subject headings as well as keywords where applicable subject headings exist.

In addition to the fact that the search does not make use of subject headings, there are still numerous terms that I would expect to see in each category: minority group*, people/person/communit*/children/men/women of color/colour, equity, unequit*, unequal*, inadequat*, underserv*, disadvant*, depriv*, disproport*, bias, discriminat*, prejud*, racism, racist, potentially barrier*, critically ill, ECMO and ARDS acronyms spelled out, septic, potentially facilitat*

I recommend the team revisit the searches with the librarian with an eye for subject headings and keywords (which you could limit to title/abstract only to keep numbers reasonable, as this is common practice for reviews), overlap this with what you've already screened and screen the difference.

Response: Co-author research librarian Hope Lappen revised and re-ran the search strategy to incorporate subject headings and additional keywords as suggested by the Reviewer. PubMed, Embase, and CINAHL were queried again with the new search strategy that included subject headings and the new keywords. Web of Science was also re-queried with the new search strategy to include the additional keywords. The Methods section is updated to reflect the new strategy (lines 101-128) and the revised search strategy for each database can be found in the updated Supplementary Material 2. An additional 813 studies were imported for screening, 39 duplicates were removed, resulting in an additional 774 studies screened. No additional studies meeting inclusion criteria were found (line 165). The PRISMA Flowchart (Figure 1) and the list of studies excluded in full-text review (S3) were updated accordingly.

Reviewer #3: Very important and necessary contribution. I appreciated reading the in-depth description of how the team developed the taxonomy as well as how you decided to include or exclude studies (i.e. studies that had the 'wrong intervention').

Response: Thank you for this kind feedback on our study analysis.

Comment: Please reframe the next steps (i.e. instead of calling for randomized control trials since it is unethical to perform this type of research in the social sciences by exposing a group to poor conditions for the purpose of investigation). Also, scoping reviews are not designed to assess the quality of research but the breadth so please update the statement that you conducted a rigorous evaluation of interventions aimed at eliminating disparities in critical care.

Response: For next steps, we suggested increased randomized control trials (RCTs, lines 314-322) because RCTs are generally the gold-standard study type to assess if an intervention is effective. Similar to the RCTs that met inclusion criteria in the scoping review, RCTs would expose study groups to a novel intervention aimed at reducing a pre-existing disparity in patient outcomes, instead of exposing a group to poor conditions to simulate a disparity. To illustrate, the RCT “Reducing Disparity in Receipt of Mother's Own Milk (ReDiMOM)” (Reference 34) randomized mother-infant pairs to either standard lactation care or an intervention designed to increase use of mother’s own milk and reduce disparities in breastfeeding rates between Black and non-Black infants. We highlight designs such as stepped-wedge cluster-randomized trials that allow all participating ICUs to benefit from the intervention under study (lines 318-320).

For assessing quality of research, we agree with the Reviewer as we discussed how we “did not seek to assess the quality of study designs because we aimed to survey current knowledge on reducing disparities in the ICU and, as our review demonstrates, research to reduce disparities is at an early state” (lines 317-318). In the Abstract, we did not aim to say that the scoping review was a rigorous evaluation of interventions, but rather that we only found a few interventions have been employed to address disparities in critical care. The Abstract has been edited to clarify this point (line 57).

Comment: The abstract notes there were 86 studies that underwent full text review but the narrative lists that number as 75. Which was it?

Response: The narrative is consistent with the abstract as eighty-six studies underwent full-text review from which 75 studies were excluded (lines 50, 188, and 193 in the tracked changes manuscript). In the revised search in response to Reviewer #2, 93 studies underwent full-text review from which 82 studies were excluded (lines 49, 165, and 168).

Comment: Since you cite the AMA's guidance on the need for the reviewed studies to define and frame race, will you elucidate the reason that your research team did not decide to also follow the AMA guidance on the reporting of race in your narrative (i.e. lowercase the 'w' in white): https://www.ama-assn.org/system/files/ama-aamc-equity-guide.pdf

Otherwise, well done.

Response: The AMA-AAMC Equity Guide that is linked in the Reviewer’s comment is a different citation than the one cited in the manuscript, Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals. JAMA. 2021;326(7):621-7 (Reference 52). The Equity Guide to which the Reviewer refers is a communication handbook for clinical practice for when physicians are speaking and referring to patients and documenting care. Our cited reference informs the updated guidelines in reporting race and ethnicity for medical and scientific publications, as found in the eleventh edition of AMA Manual of Style: A Guide for Authors and Editors. We thus followed the AMA Manual of Style and capitalized the names of races including White.

We again sincerely appreciate the time and effort of the reviewers in providing thoughtful feedback on our manuscript. We hope that our revisions address the reviewers’ concerns and that our manuscript is now suitable for publication in PLOS One. Thank you for your consideration and we look forward to your response.

Sincerely,

Mari Armstrong-Hough, PhD, MPH

Associate Professor of Epidemiology and Social & Behavioral Sciences

New York University

+1 (212) 998-9015 | mah842@nyu.edu

Shirley Ge, MD

Research Associate, AIRE Lab

New York University

+1 (978) 407-1314 | shirleyge255@gmail.com

Attachment

Submitted filename: PLOS ONE Response to Reviewers_May.docx

pone.0336922.s006.docx (129.6KB, docx)

Decision Letter 2

De-Chih Lee

16 Jul 2025

Dear Dr. Ge,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The authors are requested to accept the paper after minor revisions based on the reviewers' comments.

Please submit your revised manuscript by Aug 30 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

De-Chih Lee, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

The authors are requested to accept the paper after minor revisions based on the reviewers' comments.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #3: All comments have been addressed

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #3: Yes

Reviewer #4: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #3: Yes

Reviewer #4: Yes

**********

Reviewer #3: Great job with responding to the reviewer comments and sufficiently editing the manuscript .

Reviewer #4: Dear Authors

Great work in submitting the revised version of the manuscript. A few comments to address,

The authors have suggested the need to randomized, controlled evaluations of interventions to promote equity in critical care – However, to design a well-controlled and adequately powered RCT the cost and resources, along with the sample size will be enormous. How about considering a SWAT (Studies within a trial) to identify racial and ethic differences in interventions (just a suggestion)

Line 67, references 7 to 9 – quotes one of the author’s earlier papers, I am wondering if this will that be a potential conflict of interest for this scoping review?

Line 84, 85 – “to consolidate the available knowledge regarding interventions and quality improvement initiatives to reduce racial and ethnic disparities in critical care.”

I am not sure how much of the second objective has been satisfied with this review, it might be helpful to highlight this one.

The authors have attempted to address the racial and ethnic disparities in the studies – it might be helpful to add how much was the ethnic variability in the study team, might be interesting from a reader perspective to know about the team (please ignore this if you think it’s inappropriate)

I am not sure if PRISMA standard or PRISMA ScR checklist is suitable for use in scoping reviews?

The authors have aimed to addressed the disparities in US – just curious to know why, a few statements to strengthen why studying about US might be helpful.

In the results section – it might be helpful to mention the race and ethnicity of the population studied in the included studies.

It might be helpful to highlight the ongoing studies in table 1 with an easy identifier (different color or *) for easy identification.

Table 1 – it might be helpful to add the total number of sample size along with the % of race and ethnicity within the studies.

Table 2 is something I really liked. Well done.

It might be better to add the strengths of the study before the limitations.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

PLoS One. 2025 Nov 25;20(11):e0336922. doi: 10.1371/journal.pone.0336922.r006

Author response to Decision Letter 3


29 Aug 2025

Emily Chenette, PhD

Editor-in-Chief

PLOS One

August 11, 2025

Dear Dr. Chenette and the PLOS One Editorial Team,

Thank you for your consideration of our revised manuscript “Interventions to improve racial and ethnic equity in critical care: A scoping review”. We are grateful for the reviewers’ thoughtful and constructive feedback. We have considered each of their comments and have made the necessary revisions. Below, we provide a point-by-point response to the reviewers’ concerns. We believe these revisions have improved the rigor and impact of our manuscript. We hope that our revised manuscript now meets the standards for publication in PLOS One and look forward to your assessment.

Reviewer #3: Great job with responding to the reviewer comments and sufficiently editing the manuscript .

Thank you for this positive feedback.

Reviewer#4: Dear Authors

Great work in submitting the revised version of the manuscript. A few comments to address,

The authors have suggested the need to randomized, controlled evaluations of interventions to promote equity in critical care – However, to design a well-controlled and adequately powered RCT the cost and resources, along with the sample size will be enormous. How about considering a SWAT (Studies within a trial) to identify racial and ethic differences in interventions (just a suggestion)

We appreciate the reviewer’s suggestion to consider Studies Within a Trial (SWAT) as an alternative to large randomized controlled trials. While SWAT’s can identify subgroup differences within ongoing trials, we discussed how our results show that there is a paucity of intervention studies aiming to reduce racial or ethnic disparities in critical care despite there are already being many studies that detect racial or ethnic disparities in the ICU (Lines 269-291). Moreover, many of the studies meeting inclusion criteria focused on increasing advantageous health behaviors for all patients in practices that have been shown to have race or ethnic-based differences. These studies aimed to promote healthy behavior and then measured the impact on patients stratified by race, similar to the reviewer’s suggestion of SWAT’s (Lines 203-209).

Line 67, references 7 to 9 – quotes one of the author’s earlier papers, I am wondering if this will that be a potential conflict of interest for this scoping review?

We do not feel citing a co-author’s previous paper, Ethnic Disparities in Deep Sedation of Patients with Acute Respiratory Distress Syndrome in the United States: Secondary Analysis of a Multicenter Randomized Trial (reference 9), is a conflict of interest because we cite the paper to provide background on the evidence for ethnic disparities in ICU care in addition to several other examples from other papers by different authors (Lines 64-70, references 1-15). This paper is not included in the scoping review itself, nor would it be eligible because it does not report or evaluate an intervention.

Line 84, 85 – “to consolidate the available knowledge regarding interventions and quality improvement initiatives to reduce racial and ethnic disparities in critical care.”

I am not sure how much of the second objective has been satisfied with this review, it might be helpful to highlight this one.

We only had one primary objective to consolidate the current knowledge on interventions and quality improvement initiatives to reduce racial ethnic disparities in critical care by reviewing existing and ongoing studies (Lines 82-85). Table 1 summarizes our findings of the current knowledge and we comment on the implications of our results in the Discussion (Lines 268-351).

The authors have attempted to address the racial and ethnic disparities in the studies – it might be helpful to add how much was the ethnic variability in the study team, might be interesting from a reader perspective to know about the team (please ignore this if you think it’s inappropriate)

Our objective was to synthesize evidence on interventions to address racial and ethnic disparities in critical care, and we believe the focus should remain on the content and quality of the included studies rather than on the demographics of the review team.

I am not sure if PRISMA standard or PRISMA ScR checklist is suitable for use in scoping reviews?

Thank you for this feedback. We have replaced the PRIMSA standard checklist with the PRISMA extension for scoping reviews (PRISMA-ScR) as PRISMA-ScR is specifically for scoping reviews (Supplementary Material 1).

The authors have aimed to addressed the disparities in US – just curious to know why, a few statements to strengthen why studying about US might be helpful.

Non-U.S. studies were excluded because racial and ethnic disparities in healthcare in the United States arise from a distinct combination of historical, policy, and sociocultural factors. Studies conducted in other countries reflect disparities shaped by their own sociopolitical environments and healthcare systems, which limits the applicability and comparability of their findings to the U.S. context (Lines 361-365).

In the results section – it might be helpful to mention the race and ethnicity of the population studied in the included studies.

It might be helpful to highlight the ongoing studies in table 1 with an easy identifier (different color or *) for easy identification.

Table 1 – it might be helpful to add the total number of sample size along with the % of race and ethnicity within the studies.

Table 2 is something I really liked. Well done.

It might be better to add the strengths of the study before the limitations.

Thank you to the reviewer for these suggestions. To table 1, we added indicators for ongoing clinical trials and studies with interventions that continued to be implemented past the study period with “*” and “†”, respectively. Table 1 already includes a column for study population. Regarding the sample size and proportion of race and ethnicity within each study population, the specific demographics of participants, beyond the targeted population already included in the table, are not relevant to answering the study objective. We sought to consolidate the current knowledge on interventions and quality improvement initiatives to reduce racial ethnic disparities in critical care by reviewing existing and ongoing studies in a scoping review (Lines 82-85). Unlike a systematic review, demographics and outcomes of included studies are not always necessary to answer the research question.

We again sincerely appreciate the time and effort of the reviewers in providing thoughtful feedback on our manuscript. We hope that our revisions address the reviewers’ concerns and that our manuscript is now suitable for publication in PLOS One. Thank you for your consideration and we look forward to your response.

Sincerely,

Mari Armstrong-Hough, PhD, MPH

Associate Professor of Epidemiology and Social & Behavioral Sciences

New York University

+1 (212) 998-9015 | mah842@nyu.edu

Shirley Ge, MD

Research Associate, AIRE Lab

New York University

+1 (978) 407-1314 | shirleyge255@gmail.com

Attachment

Submitted filename: PLOS ONE Response to Reviewers_Aug_mah.docx

pone.0336922.s007.docx (129.7KB, docx)

Decision Letter 3

De-Chih Lee

3 Oct 2025

Dear Dr. Ge,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please make minor revisions according to the second reviewer's comments and then accept the revised manuscript.

Please submit your revised manuscript by Nov 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

De-Chih Lee, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please make minor revisions according to the second reviewer's comments and then accept the revised manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #3: No

Reviewer #4: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #3: Yes

Reviewer #4: Yes

**********

Reviewer #3: Great job responding in detail to all of the reviewer comments thus far. One last question I have is why your team did not elect to rely on 3 researchers for the screening/review of studies (2 initial reviewers and 1 to break ties). This is the standard way to pursue interrater reliability. Please add a line as to why you opted to rely on 2 researchers rather than 3.

Reviewer #4: Dear Authors,

The submitted manuscript reads very well.

Please modify the PRISMA to PRISMA ScR (more than two places still read as PRISMA). In the discussion, I will encourage you to add the strengths of the study before the limitations (content from line 366-371 may be placed before line 352).

All the best!

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #3: Yes:  Maranda Ward

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

PLoS One. 2025 Nov 25;20(11):e0336922. doi: 10.1371/journal.pone.0336922.r008

Author response to Decision Letter 4


20 Oct 2025

Dear Dr. Chenette and the PLOS One Editorial Team,

Thank you for your consideration of our revised manuscript “Interventions to improve racial and ethnic equity in critical care: A scoping review”. We are grateful for the reviewers’ thoughtful and constructive feedback. We have considered each of their comments and have made the necessary revisions. Below, we provide a point-by-point response to the reviewers’ concerns. We believe these revisions have improved the rigor and impact of our manuscript. We hope that our revised manuscript now meets the standards for publication in PLOS One and look forward to your assessment.

Reviewer #3: Great job responding in detail to all of the reviewer comments thus far. One last question I have is why your team did not elect to rely on 3 researchers for the screening/review of studies (2 initial reviewers and 1 to break ties). This is the standard way to pursue interrater reliability. Please add a line as to why you opted to rely on 2 researchers rather than 3.

Research librarian Hope Lappen was often consulted as the third reviewer on studies for which the initial two reviewers had difficulty reaching a consensus. A consensus was reached with Lappen’s expertise or with Lappen casting a tie-breaking vote. Her role as the third reviewer was added to the Methods section (Line 139-140).

Reviewer #4: Dear Authors,

The submitted manuscript reads very well.

Please modify the PRISMA to PRISMA ScR (more than two places still read as PRISMA). In the discussion, I will encourage you to add the strengths of the study before the limitations (content from line 366-371 may be placed before line 352).

All the best!

PRISMA was modified to PRISMA-ScR in the manuscript text and in the title of Figure 1. The discussion of the study strengths was moved before the limitations.

We again sincerely appreciate the time and effort of the reviewers in providing thoughtful feedback on our manuscript. We hope that our revisions address the reviewers’ concerns and that our manuscript is now suitable for publication in PLOS One. Thank you for your consideration and we look forward to your response.

Sincerely,

Mari Armstrong-Hough, PhD, MPH

Associate Professor of Epidemiology and Social & Behavioral Sciences

New York University

+1 (212) 998-9015 | mah842@nyu.edu

Shirley Ge, MD

Research Associate, AIRE Lab

New York University

+1 (978) 407-1314 | shirleyge255@gmail.com

Attachment

Submitted filename: PLOS ONE Response to Reviewers_Oct.docx

pone.0336922.s008.docx (126.2KB, docx)

Decision Letter 4

De-Chih Lee

2 Nov 2025

Interventions to improve racial and ethnic equity in critical care: A scoping review

PONE-D-24-49820R4

Dear Dr. Ge,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

De-Chih Lee, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #3: Yes

Reviewer #4: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #3: Yes

Reviewer #4: Yes

**********

Reviewer #3: Authors thoroughly and carefully responded to all of the reviewer comments. Very well done, look forward to this publication being widely available.

Reviewer #4: Dear Authors

Great job in making the changes. I would suggest you to change reference 27 in the article to this one please "Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4. PMID: 30178033."

All the best!

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #3: Yes:  Maranda C. Ward

Reviewer #4: No

**********

Acceptance letter

De-Chih Lee

PONE-D-24-49820R4

PLOS ONE

Dear Dr. Ge,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. De-Chih Lee

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist.

    (DOCX)

    pone.0336922.s001.docx (84.8KB, docx)
    S1 Database. Database Search Strategies.

    (DOCX)

    pone.0336922.s002.docx (18.6KB, docx)
    S1 Text. Studies Excluded in Full-Text Review.

    (DOCX)

    pone.0336922.s003.docx (30.4KB, docx)
    Attachment

    Submitted filename: PLOS ONE Response to Reviewers_final.docx

    pone.0336922.s005.docx (129.3KB, docx)
    Attachment

    Submitted filename: PLOS ONE Response to Reviewers_May.docx

    pone.0336922.s006.docx (129.6KB, docx)
    Attachment

    Submitted filename: PLOS ONE Response to Reviewers_Aug_mah.docx

    pone.0336922.s007.docx (129.7KB, docx)
    Attachment

    Submitted filename: PLOS ONE Response to Reviewers_Oct.docx

    pone.0336922.s008.docx (126.2KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES